nach oben

Erschienen in:

11.01.2024 | Original Article

Association of serum osteocalcin with bone microarchitecture and muscle mass in Beijing community-dwelling postmenopausal women

verfasst von: Shuying Liu, Qianqian Pang, Wenmin Guan, Fan Yu, Ou Wang, Mei Li, Xiaoping Xing, Wei Yu, Yan Jiang, Weibo Xia

Erschienen in: Endocrine | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

Osteoporosis is a systemic skeletal disease with increasing bone fragility and prone to fracture. Osteocalcin (OC), as the most abundant non collagen in bone matrix, has been extensively used in clinic as a biochemical marker of osteogenesis. Two forms of OC were stated on circulation, including carboxylated osteocalcin (cOC) and undercarboxylated osteocalcin (ucOC). OC was not only involved in bone mineralization, but also in the regulation of muscle function.

Objective

This study explored the relationship between serum OC, cOC, ucOC levels and bone mineral density (BMD), bone microarchitecture, muscle mass and physical activity in Chinese postmenopausal women.

Method

216 community-dwelling postmenopausal women were randomized enrolled. All subjects completed biochemical measurements, including serum β-isomer of C-terminal telopeptides of type I collagen (β-CTX), N-terminal propeptide of type 1 procollagen (P1NP), alkaline phosphatase (ALP), OC, cOC and ucOC. They completed X-ray absorptiometry (DXA) scan to measure BMD, appendicular lean mass (ALM) and trabecular bone score (TBS). They completed high resolution peripheral quantitative CT (HR-pQCT) to assess peripheral bone microarchitectures.

Results

Serum OC, cOC and ucOC were elevated in osteoporosis postmenopausal women. In bone geometry, serum ucOC was positively related with total bone area (Tt.Ar) and trabecular area(Tb.Ar). In bone volumetric density, serum OC and ucOC were negatively associated with total volume bone mineral density (Tt.vBMD) and trabecular volume bone mineral density (Tb.vBMD). In bone microarchitecture, serum OC and ucOC were negatively correlative with Tb.N and Tb.BV/TV, and were positively correlated with Tb.Sp. Serum OC and ucOC were positively associated with Tb.1/N.SD. Serum OC was negatively related with Tb.Th. Serum ucOC was positively associated with ALM. The high level of serum OC was the risk factor of osteoporosis. ALM was the protective factor for osteoporosis.

Conclusion

All forms of serum OC were negatively associated with BMD. Serum OC and ucOC mainly influenced microstructure of trabecular bone in peripheral skeletons. Serum ucOC participated in modulating both bone microstructure and muscle mass.

N.A. listed, Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am. J. Med. 94, 646–650 (1993). https://doi.org/10.1016/0002-9343(93)90218-eCrossRef

N.E. Lane, Epidemiology, etiology, and diagnosis of osteoporosis. Am. J. Obstet. Gynecol. 194, S3–S11 (2006). https://doi.org/10.1016/j.ajog.2005.08.047CrossRefPubMed

Research, C.S.o.O.A.B.M, Epidemiological survey of osteoporosis in China and release of the results of the special action of “healthy bones”. Chin. J. Osteoporos. Bone Min. Res. 4, 317–318 (2019)

P.D. Delmas, R. Eastell, P. Garnero, M.J. Seibel, J. Stepan; Committee of Scientific Advisors of the International Osteoporosis, The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation. Osteoporos. Int. 11, S2–S17 (2000). https://doi.org/10.1007/s001980070002CrossRefPubMed

P.V. Hauschka, J.B. Lian, D.E. Cole, C.M. Gundberg, Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol. Rev. 69, 990–1047 (1989). https://doi.org/10.1152/physrev.1989.69.3.990CrossRefPubMed

C. Vermeer, K.S. Jie, M.H. Knapen, Role of vitamin K in bone metabolism. Annu Rev. Nutr. 15, 1–22 (1995). https://doi.org/10.1146/annurev.nu.15.070195.000245CrossRefPubMed

T. Komori, What is the function of osteocalcin? J. Oral. Biosci. 62, 223–227 (2020). https://doi.org/10.1016/j.job.2020.05.004CrossRefPubMed

L. Jia, M. Cheng, Correlation analysis between risk factors, BMD and serum osteocalcin, CatheK, PINP, β-crosslaps, TRAP, lipid metabolism and BMI in 128 patients with postmenopausal osteoporotic fractures. Eur. Rev. Med Pharm. Sci. 26, 7955–7959 (2022). https://doi.org/10.26355/eurrev_202211_30147CrossRef

F. Lumachi, V. Camozzi, V. Tombolan, G. Luisetto, Bone mineral density, osteocalcin, and bone-specific alkaline phosphatase in patients with insulin-dependent diabetes mellitus. Ann. N. Y Acad. Sci. 1173(Suppl 1), E64–E67 (2009). https://doi.org/10.1111/j.1749-6632.2009.04955.xCrossRefPubMed

10.

J.T. Chen, K. Hosoda, K. Hasumi, E. Ogata, M. Shiraki, Serum N-terminal osteocalcin is a good indicator for estimating responders to hormone replacement therapy in postmenopausal women. J. Bone Min. Res 11, 1784–1792 (1996). https://doi.org/10.1002/jbmr.5650111123CrossRef

11.

K.J. Kim, K.M. Kim, K.H. Park, H.S. Choi, Y. Rhee, Y.H. Lee, B.S. Cha, M.J. Kim, S.M. Oh, J.K. Brown, S.K. Lim, Aortic calcification and bone metabolism: the relationship between aortic calcification, BMD, vertebral fracture, 25-hydroxyvitamin D, and osteocalcin. Calcif. Tissue Int 91, 370–378 (2012). https://doi.org/10.1007/s00223-012-9642-1CrossRefPubMed

12.

M. Papageorgiou, T. Sathyapalan, R. Schutte, Muscle mass measures and incident osteoporosis in a large cohort of postmenopausal women. J. Cachexia Sarcopenia Muscle 10, 131–139 (2019). https://doi.org/10.1002/jcsm.12359CrossRefPubMed

13.

S.Y. Jang, J. Park, S.Y. Ryu, S.W. Choi, Low muscle mass is associated with osteoporosis: A nationwide population-based study. Maturitas 133, 54–59 (2020). https://doi.org/10.1016/j.maturitas.2020.01.003CrossRefPubMed

14.

Y. Pan, J. Xu, Association between muscle mass, bone mineral density and osteoporosis in type 2 diabetes. J. Diabetes Investig. 13, 351–358 (2022). https://doi.org/10.1111/jdi.13642CrossRefPubMed

15.

D. Scott, A. Hayes, K.M. Sanders, D. Aitken, P.R. Ebeling, G. Jones, Operational definitions of sarcopenia and their associations with 5-year changes in falls risk in community-dwelling middle-aged and older adults. Osteoporos. Int. 25, 187–193 (2014). https://doi.org/10.1007/s00198-013-2431-5CrossRefPubMed

16.

E. Sornay-Rendu, F. Duboeuf, S. Boutroy, R.D. Chapurlat, Muscle mass is associated with incident fracture in postmenopausal women: The OFELY study. Bone 94, 108–113 (2017). https://doi.org/10.1016/j.bone.2016.10.024CrossRefPubMed

17.

F. Vigevano, G. Gregori, G. Colleluori, R. Chen, V. Autemrongsawat, N. Napoli, C. Qualls, D.T. Villareal, R. Armamento-Villareal, In Men With Obesity, T2DM Is Associated With Poor Trabecular Microarchitecture and Bone Strength and Low Bone Turnover. J. Clin. Endocrinol. Metab. 106, 1362–1376 (2021). https://doi.org/10.1210/clinem/dgab061CrossRefPubMedPubMedCentral

18.

K. Fulzele, D.J. DiGirolamo, Z. Liu, J. Xu, J.L. Messina, T.L. Clemens, Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and action. J. Biol. Chem. 282, 25649–25658 (2007). https://doi.org/10.1074/jbc.M700651200CrossRefPubMed

19.

P. Mera, K. Laue, M. Ferron, C. Confavreux, J. Wei, M. Galán-Díez, A. Lacampagne, S.J. Mitchell, J.A. Mattison, Y. Chen, J. Bacchetta, P. Szulc, R.N. Kitsis, R. de Cabo, R.A. Friedman, C. Torsitano, T.E. McGraw, M. Puchowicz, I. Kurland, G. Karsenty, Osteocalcin signaling in myofibers is necessary and sufficient for optimum adaptation to exercise. Cell Metab. 23, 1078–1092 (2016). https://doi.org/10.1016/j.cmet.2016.05.004CrossRefPubMedPubMedCentral

20.

W. Xia, Q. Liu, J. Lv, Z. Zhang, W. Wu, Z. Xie, J. Chen, L. He, J. Dong, Z. Hu, Q. Lin, W. Yu, F. Wei, J. Wang, Prevalent vertebral fractures among urban-dwelling Chinese postmenopausal women: a population-based, randomized-sampling, cross-sectional study. Arch. Osteoporos. 17, 120 (2022). https://doi.org/10.1007/s11657-022-01158-xCrossRefPubMedPubMedCentral

21.

J.A. Kanis, L.J. Melton 3rd, C. Christiansen, C.C. Johnston, N. Khaltaev, The diagnosis of osteoporosis. J. Bone Min. Res. 9, 1137–1141 (1994). https://doi.org/10.1002/jbmr.5650090802CrossRef

22.

S. Boutroy, M.L. Bouxsein, F. Munoz, P.D. Delmas, In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. J. Clin. Endocrinol. Metab. 90, 6508–6515 (2005). https://doi.org/10.1210/jc.2005-1258CrossRefPubMed

23.

S. Perera, S.H. Mody, R.C. Woodman, S.A. Studenski, Meaningful change and responsiveness in common physical performance measures in older adults. J. Am. Geriatr. Soc. 54, 743–749 (2006). https://doi.org/10.1111/j.1532-5415.2006.00701.xCrossRefPubMed

24.

M. Iki, T. Akiba, T. Matsumoto, H. Nishino, S. Kagamimori, Y. Kagawa, H. Yoneshima; JPOS Study Group, Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese Population-based Osteoporosis (JPOS) Study. Osteoporos. Int. 15, 981–991 (2004). https://doi.org/10.1007/s00198-004-1634-1CrossRefPubMed

25.

S.S. Diemar, L.T. Møllehave, N. Quardon, L. Lylloff, B.H. Thuesen, A. Linneberg, N.R. Jørgensen, Effects of age and sex on osteocalcin and bone-specific alkaline phosphatase-reference intervals and confounders for two bone formation markers. Arch. Osteoporos. 15, 26 (2020). https://doi.org/10.1007/s11657-020-00715-6CrossRefPubMed

26.

Y. Xu, L. Shen, L. Liu, Z. Zhang, W. Hu, Undercarboxylated osteocalcin and its associations with bone mineral density, bone turnover markers, and prevalence of osteopenia and osteoporosis in chinese population: a cross-sectional study. Front Endocrinol. (Lausanne) 13, 843912 (2022). https://doi.org/10.3389/fendo.2022.843912CrossRefPubMed

27.

S.M. Kim, K.M. Kim, B.T. Kim, N.S. Joo, K.N. Kim, D.J. Lee, Correlation of undercarboxylated osteocalcin (ucOC) concentration and bone density with age in healthy Korean women. J. Korean Med Sci. 25, 1171–1175 (2010). https://doi.org/10.3346/jkms.2010.25.8.1171CrossRefPubMedPubMedCentral

28.

G. Gutierrez-Buey, P. Restituto, S. Botella, I. Monreal, I. Colina, M. Rodríguez-Fraile, A. Calleja, N. Varo, Trabecular bone score and bone remodelling markers identify perimenopausal women at high risk of bone loss. Clin. Endocrinol. (Oxf.) 91, 391–399 (2019). https://doi.org/10.1111/cen.14042CrossRefPubMed

29.

K. Kerschan-Schindl, E. Boschitsch, R. Marculescu, R. Gruber, P. Pietschmann, Bone turnover markers in serum but not in saliva correlate with bone mineral density. Sci. Rep. 10, 11550 (2020). https://doi.org/10.1038/s41598-020-68442-zCrossRefPubMedPubMedCentral

30.

P. Szulc, M. Arlot, M.C. Chapuy, F. Duboeuf, P.J. Meunier, P.D. Delmas, Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J. Bone Min. Res. 9, 1591–1595 (1994). https://doi.org/10.1002/jbmr.5650091012CrossRef

31.

N. Emaus, N.D. Nguyen, B. Almaas, G.K. Berntsen, J.R. Center, M. Christensen, C.G. Gjesdal, A.S. Grimsgaard, T.V. Nguyen, L. Salomonsen, J.A. Eisman, V.M. Fønnebø, Serum level of under-carboxylated osteocalcin and bone mineral density in early menopausal Norwegian women. Eur. J. Nutr. 52, 49–55 (2013). https://doi.org/10.1007/s00394-011-0285-1CrossRefPubMed

32.

Å. Bjørnerem, A. Ghasem-Zadeh, M. Bui, X. Wang, C. Rantzau, T.V. Nguyen, J.L. Hopper, R. Zebaze, E. Seeman, Remodeling markers are associated with larger intracortical surface area but smaller trabecular surface area: A twin study. Bone 49, 1125–1130 (2011). https://doi.org/10.1016/j.bone.2011.08.009CrossRefPubMed

33.

S. Atalay, A. Elci, H. Kayadibi, C.B. Onder, N. Aka, Diagnostic utility of osteocalcin, undercarboxylated osteocalcin, and alkaline phosphatase for osteoporosis in premenopausal and postmenopausal women. Ann. Lab. Med. 32, 23–30 (2012). https://doi.org/10.3343/alm.2012.32.1.23CrossRefPubMed

34.

S.H. Rønn, T. Harsløf, S.B. Pedersen, B.L. Langdahl, Vitamin K2 (menaquinone-7) prevents age-related deterioration of trabecular bone microarchitecture at the tibia in postmenopausal women. Eur. J. Endocrinol. 175, 541–549 (2016). https://doi.org/10.1530/EJE-16-0498CrossRefPubMed

35.

I. Zofková, M. Hill, V. Palicka, Association between serum undercarboxylated osteocalcin and bone density and/or quality in early postmenopausal women. Nutrition 19, 1001–1003 (2003). https://doi.org/10.1016/s0899-9007(03)00179-5CrossRefPubMed

36.

C.M. Gundberg, S.D. Nieman, S. Abrams, H. Rosen, Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. J. Clin. Endocrinol. Metab. 83, 3258–3266 (1998). https://doi.org/10.1210/jcem.83.9.5126CrossRefPubMed

37.

P. Vergnaud, P. Garnero, P.J. Meunier, G. Bréart, K. Kamihagi, P.D. Delmas, Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J. Clin. Endocrinol. Metab. 82, 719–724 (1997). https://doi.org/10.1210/jcem.82.3.3805CrossRefPubMed

38.

P. Szulc, M.C. Chapuy, P.J. Meunier, P.D. Delmas, Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J. Clin. Invest 91, 1769–1774 (1993)CrossRefPubMedPubMedCentral

39.

J.A. Vitale, V. Sansoni, M. Faraldi, C. Messina, C. Verdelli, G. Lombardi, S. Corbetta, Circulating carboxylated osteocalcin correlates with skeletal muscle mass and risk of fall in postmenopausal osteoporotic women. Front Endocrinol. (Lausanne) 12, 669704 (2021). https://doi.org/10.3389/fendo.2021.669704CrossRefPubMed

40.

X. Lin, C. Smith, A. Moreno-Asso, N. Zarekookandeh, T.C. Brennan-Speranza, G. Duque, A. Hayes, I. Levinger, Undercarboxylated osteocalcin and ibandronate combination ameliorates hindlimb immobilization-induced muscle wasting. J. Physiol. 601, 1851–1867 (2023). https://doi.org/10.1113/JP283990CrossRefPubMed

41.

P. Mera, K. Laue, J. Wei, J.M. Berger, G. Karsenty, Osteocalcin is necessary and sufficient to maintain muscle mass in older mice. Mol. Metab. 5, 1042–1047 (2016). https://doi.org/10.1016/j.molmet.2016.07.002CrossRefPubMedPubMedCentral

42.

M. Ferron, J. Wei, T. Yoshizawa, A. Fattore, R. DePinho, A. Teti, P. Ducy, G. Karsenty, Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 142, 296–308 (2010). https://doi.org/10.1016/j.cell.2010.06.003CrossRefPubMedPubMedCentral

43.

X. Lin, L. Parker, E. McLennan, A. Hayes, G. McConell, T.C. Brennan-Speranza, I. Levinger, Undercarboxylated osteocalcin improves insulin-stimulated glucose uptake in muscles of corticosterone-treated mice. J. Bone Min. Res. 34, 1517–1530 (2019). https://doi.org/10.1002/jbmr.3731CrossRef

44.

D. Hiam, S. Landen, M. Jacques, S. Voisin, J. Alvarez-Romero, E. Byrnes, P. Chubb, I. Levinger, N. Eynon, Osteocalcin and its forms respond similarly to exercise in males and females. Bone 144, 115818 (2021). https://doi.org/10.1016/j.bone.2020.115818CrossRefPubMed

45.

J. Fan, N. Li, X. Gong, L. He, Serum 25-hydroxyvitamin D, bone turnover markers and bone mineral density in postmenopausal women with hip fractures. Clin. Chim. Acta 477, 135–140 (2018). https://doi.org/10.1016/j.cca.2017.12.015CrossRefPubMed

Titel: Association of serum osteocalcin with bone microarchitecture and muscle mass in Beijing community-dwelling postmenopausal women
verfasst von: Shuying Liu
Qianqian Pang
Wenmin Guan
Fan Yu
Ou Wang
Mei Li
Xiaoping Xing
Wei Yu
Yan Jiang
Weibo Xia
Publikationsdatum: 11.01.2024
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 1/2024
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-023-03668-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Association of serum osteocalcin with bone microarchitecture and muscle mass in Beijing community-dwelling postmenopausal women